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Abstract: Living beings spend their lives and carry out their daily activities interacting with
environmental situations that present space-time variations and that involve contact with other life
forms, which may behave as commensals or as invaders and/or parasites. The characteristics of the
environment, as well as the processes that support the maintenance of life and that characterize
the execution of activities of daily life generally present periodic variations, which are mostly
synchronized with the light–dark cycle determined by Earth’s rotation on its axis. These rhythms
with 24-h periodicity, defined as circadian, influence events linked to the interaction between hosts
and hosted microorganisms and can dramatically determine the outcome of this interplay. As for
the various pathological conditions resulting from host–microorganism interactions, a particularly
interesting scenario concerns infections by viruses. When a viral agent enters the body, it alters the
biological processes of the infected cells in order to favour its replication and to spread to various
tissues. Though our knowledge concerning the mutual influence between the biological clock and
viruses is still limited, recent studies start to unravel interesting aspects of the clock–virus molecular
interplay. Three different aspects of this interplay are addressed in this mini-review and include the
circadian regulation of both innate and adaptive immune systems, the impact of the biological clock
on viral infection itself, and finally the putative perturbations that the virus may confer to the clock
leading to its deregulation.
Keywords: clock; circadian rhythms; virus; host; immune system
1. Introduction
Rotation of the planet Earth around its axis generates rhythmic day/night alternations with a
period of approximately 24 h (circadian). The term circadian originates from the Latin circa dies,
“approximately one day”, more or less the time length of day/night or light/dark cycles. Circadian
rhythms, generated by the endogenous circadian clock, allow living beings to anticipate environmental
daily changes and provide an evolutionary advantage that favours survival despite strong selective
pressure. The circadian clock is evolutionary conserved and thought to be roughly 2.5 billion years
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old, tracing back to cyanobacteria, which started releasing vast amounts of oxygen during the Great
Oxidation Event, prior (700 million years) to the divergence of plants, animals, and fungal lineages [1–3].
The biological clock is a molecular network which generates oscillations in gene and protein
expression that control cellular functioning and allows for the timely separation of biological processes
that cannot or should not coexist. These include redox reactions and DNA replication [4], switches in
metabolic pathways [5–7], as well as behavioural and physiological rhythms [8]. The endogenously
driven rhythms are synchronized by external cues, such as environmental light and temperature, and
feeding times [4,7,9] and are resilient to temperature fluctuations within the physiological range [10,11].
1.1. The Circadian Clock Circuitry
In mammals, the system driving the generation of internal timing and ultimately the regulation of
physiology and behaviour is formed by a hierarchical network of biological oscillators with two hubs
in the hypothalamic suprachiasmatic nuclei (SCN) [12]. The SCN clock (main pacemaker) is necessary
for the maintenance of 24-h body rhythms [13,14] and can restore [15] or de novo establish circadian
rhythms in gene expression when transplanted in genetically arrhythmic mice [16,17]. The circadian
circuitry encompasses molecular clocks of the main pacemaker and additional cellular clocks in
peripheral tissues [18–20]. These are driven by the SCN through neural and humoral outputs [21]
and, together with the main pacemaker, manage circadian timing of physiological processes and
behaviour [2,22]. One of the main external synchronizers (or zeitgeber) is light, a strong central
pacemaker-tuning cue [23]. Light information is perceived by retinal ganglion cells expressing the
photopigment melanopsin and passed on to the SCN through retino-hypothalamic tract fibres [24–27]
and to neighbouring and downstream oscillators via neurotransmitters such as glutamate, PACAP,
VIP, GRP [25,28,29], VP [30,31], and GABA [32]. Even though the oscillators in the SCN are capable of
autonomous ticking, the oscillations become progressively dampened in peripheral oscillators in the
absence of SCN-synchronizing signals [33].
1.2. The Molecular Mechanisms of Biological Ticking
The molecular clockworks generate rhythmic oscillations through “transcription-translation
feedback loops” (TTFL), i.e., core-clock transcription factors positively turn on the expression of
genes encoding circadian proteins that subsequently inhibit transcription via negative-feedback loops,
with a time delay indispensable for the proper functioning of the biological clock [34]. The TTFL is
manoeuvred by several core-clock mRNAs and proteins, including activators (BMAL1, CLOCK, RORα,
RORβ, and RORγ) and repressors (PER1, PER2, PER3, CRY1, CRY2, REV-ERBα, and REV-ERBβ),
kinases (CKIα, CKIδ, and CKIε), and phosphatases (PP1 and PP5) that control protein stability and
subcellular localization. CLOCK (or its paralogue NPAS2) and BMAL1 (alias ARNTL), as basic
helix-loop-helix-PAS (bHLH–PAS) transcription factors [34] heterodimerize and bind to E-boxes in the
promoter regions of the genes encoding the period (PER1, PER2, and PER3) and cryptochrome (CRY1
and CRY2) proteins, which upon heterodimerization in the cytoplasm translocate back into the nucleus
and repress CLOCK:BMAL1-mediated transcription. Then, ubiquitination-dependent degradation
of PER/CRY complexes takes place and a new round of CLOCK:BMAL1-mediated transcription
restarts [34].
In addition, the nuclear receptors REV-ERBα and REV-ERBβ compete with RORα, RORβ,
and RORγ at ROR-binding elements (ROREs) in the promoter region of BMAL1 and fine-tune its
transcription [34]. The CLOCK:BMAL1 heterodimer activates another auxiliary loop operated by the
PAR-bZip transcription factors D-Box Binding PAR BZIP (DBP), Thyrotrophic Embryonic Factor (TEF),
and Hepatic Leukemia Factor (HLF); bind to D-box-containing sites within the promoter region of the
transcriptional repressor NFIL3 (alias E4BP4); and prompts numerous downstream transcriptional
events [34].
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1.3. Viruses and Circadian Clock Circuits
Synchronization with the external environment and anticipation of predictable environmental
changes confer competitive advantages to living beings, especially in the wild. Accordingly, in humans
experiencing dysregulation of circadian timing, for example, due to shift work or social jet lag,
there is increased incidence of various degenerative, inflammatory, metabolic, and neoplastic
diseases [35,36]. Besides human health and wellbeing maintenance, a detailed knowledge of the
molecular mechanisms operating biological clocks has implications also for the efficacy of treatment
strategies for pathological states.
Mounting evidence shows that time-of-day-related treatment schedules and chrono-modulated
drug delivery significantly affect both effectiveness and side effects of pharmacological therapy [37–39].
Diseases caused by viruses, rickettsiae, bacteria, fungi, or parasites continue to represent a primary
cause of morbidity. Infections by viruses rework the biological processes of infected cells to facilitate
replication and spread, and thus the molecular interplay between the mechanisms of the biological
clock, immune system, and virus infection can influence disease outcomes (Figure 1).
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The interaction of virions and their nucleic acid core with these two players impacts viral replication
and rhythmic patterns of host–hosted molecular tra e off. The immune system with its innate and
adaptive arms provides shielding against viral infections with a number of molecular factors and
effectors, such as dendritic cells, T and B cells, macrophages, and natural killer cells. These are engaged
to hold up and hinder virus replication and dissemination through the secretion of cytokines and
the production of specific antibodies. The components and, ultimately, the complex function of the
immune system are rhythmically driven by the biological clock and, in turn, influence the function of
the molecular clockwork. Viral particles impact the interplay between immune and circadian systems.
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1.4. Circadian Regulation of Both Innate and Adaptive Immune Systems
The circadian regulation of the immune system response allows for its time-dependent success
against different pathogens in a rhythmic fashion [40–44]. Immune cells of the innate and adaptive
components of the immune system have molecular clockworks managing their rhythmic processes on
a 24-h timescale [45–49], such as lymphocyte migration through lymph nodes and lymph in mice [50].
The rhythmic function of the immune system influences the appearance of pathological conditions,
for instance, inflammatory lung disease and asthma, which show circadian fluctuations in symptoms
and occurrence. In a recent study using both acute and chronic models of virus-induced airway disease
(based on the Sendai virus (SeV)), disturbance of the 24-h periodicity negatively affected development,
progression, and exacerbation of asthma [51]. In this study, BMAL1 silencing lead to more pronounced
asthma-typical airway changes, which suggests a role for BMAL1 in the regulation of lung-specific
antiviral responses and the subsequent development of asthmatic symptoms. This study reinforces
the previous findings from Majumdar et al., who reported a role for BMAL1 as a regulator of innate
immunity and showed that BMAL1-deficent cells are more susceptible to infection of the RNA viruses
RSV (respiratory syncytial virus) and PIV3 (parainfluenza virus type 3) [52].
The efficacy of vaccination is also thought to be under circadian control as suggested by results
obtained in mice and human studies. Silver et al. have shown in immunized mice that vaccination at
the time of higher TLR9 (Toll-like receptor 9) expression led to enhanced immune response, likely due
to the circadian expression pattern of TLR9 [44]. Interestingly, in the same study, PER2-deficient mice
did not show the observed time variation of immune response. Likewise, the antibody response to
viral challenge in humans was also reported to be time dependent: immunization with hepatitis A and
influenza virus vaccines in the morning led to higher antibody response as compared to afternoon
vaccination [53–55].
1.5. Influence of the Biological Clock on Virus Replication Cycle and Disease
Cellular and tissue functions exhibit rhythmic fluctuations over the course of 24 h that impact the
susceptibility to or progression of the viral infection. Several core-clock elements have been reported
to modulate viral infection. BMAL1 and PER2 are regulators of antiviral immunity, as described in
the previous section, and additional roles for PER1 and REV-ERBα, as well as melatonin have been
highlighted, as described in the following. The seasonal variation of BMAL1 expression, reaching its
lowest values in winter, seems to contribute to the high occurrence of respiratory viral diseases in this
season since low BMAL1 expression enhances viral disease [56,57]. An effect of the circadian clock in
viral infection was also reported for wild-type mice infected with murine herpesvirus 4 at different times
of the day. The mice were kept under controlled temperature and lighting environment (12-h light/12-h
darkness), and the levels of infection and spread of the virus were evaluated [58]. In mice infected at the
beginning of the day, corresponding to the beginning of the resting phase of these nocturnal animals,
the viral replication was increased tenfold compared to the values measured in mice infected during the
night period, corresponding to the activity phase. In mice lacking BMAL1, the levels of virus replication
were independent of the time of day at which the viral infection was performed [58]. The effect of time
of infection on virus replication was independent of the immune system, as also confirmed on single cell
cultures (embryonic fibroblasts), in which several time-dependent processes (intracellular trafficking,
biosynthetic processes, protein synthesis, and chromatin assembly) were involved. The obliteration
of cellular circadian rhythms increased the replication of herpes and influenza A viruses, which lost
rhythmic fluctuation and remained persistently high [58]. The time of day of herpes simplex virus
type 2 (HSV-2) infection impacted the outcome of the pathology in wild-type mice kept under 12-h
light and 12-h darkness (LD 12:12), probably due to the circadian rhythmic expression of the HSV-2
receptor in the skin Nectin1. This effect was confirmed in immunodeficient RAG2-knockout mice [59].
Moreover, the core-clock gene PER1 was identified as a negative regulator of HIV-1 transcription
and its expression inversely correlated with viral loads, likely in relation to different latencies of the
virus in resting CD4+ T-cells [60].
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Liver infection caused by hepatitis B and C viruses was also reported to be under circadian
control. REV-ERBα plays an indirect role in Hepatitis C Virus (HCV) infection by negatively
regulating miR122 [61], a microRNA known for its essential role in HCV replication [62]. In addition,
PER2 overexpression decreased HCV RNA replication in permissive hepatocyte-derived cells.
Interestingly PER2 can influence interferon signalling, which is a known player in regulating both the
innate and the adaptive antiviral response and viral replication [46]. Enhanced expression of interferon
was also observed as a result of melatonin administration in a mouse model of VEE (Venezuelan equine
encephalomyelitis). Melatonin is a well-known component of the circadian system; this hormone is
produced with 24-h rhythmicity by the pineal gland and has been associated with improved response
against viruses. This study showed that melatonin administration results in decreased mortality upon
VEE infection [63]. Melatonin was successfully applied against the respiratory syncytial virus (RSV),
a pathogen causing severe disease in children, resulting in increased survival of newborn children with
RSV-related respiratory sepsis [64]. In addition, the administration of melatonin in the treatment of
individuals who are infected with the Ebola virus was reported to reduce several pathological changes
caused by the virus to the host, and thus melatonin seems to be an interesting nontoxic candidate for
future studies on antagonists of viral infections [65].
Another important interaction involves BMAL1 and the HSV transcriptional machinery. BMAL1
is able to associate with the regulatory protein ICP0 [66]; it forms heterodimers with the histone
acetyltransferase CLOCK and localizes at ND10 nuclear bodies. Viral proteins stabilize the heterodimer
and enzymatically activate CLOCK, which associates with the transcriptional complex (ICP4, ICP27,
ICP22, and TFIID), linking the replicative cycle of the virus to the molecular clockwork [67].
1.6. Disruption of the Circadian Clock by Viruses
Viral infection may also alter circadian gene expression as reported in different studies. Simian
immunodeficiency virus (SIV) infection in monkeys caused changes in amplitude and values of body
temperature and locomotor activity circadian rhythmicity after the acute retroviral syndrome stage.
These changes were not linked to modifications detected in the acute febrile response triggered by virus
inoculation. On the other hand, hypothalamic microglia infiltration and macrophage accumulation
were shown to occur in animals sacrificed upon appearance of strong circadian anomalies, hinting at
analogously significant physiological and psycho-cognitive consequences in human subjects with HIV
infection [68]. Moreover, in vitro experiments performed in a cell line (Bel-7404-HBx) stably transfected
with the hepatitis B virus X protein (HBx, involved in hepatocellular carcinogenesis) showed alterations
in the mRNA expression levels for several core-clock genes, with upregulation of CLOCK, PER1,
and PER2 and downregulation of BMAL1, PER3, CRY1, CRY2, and CKIε [69].
1.7. The Biological Clock and Influenza Virus Infection
A worldwide problem is represented by seasonal epidemics of influenza. Influenza is a disease
with global impact that causes enormous morbidity and mortality on an annual basis. The severity of
the infection depends on both the virus strain and a number of host factors, primarily age and the
presence of comorbid conditions. The mortality and usage of healthcare resources associated with
influenza is focused in the elderly and in those with a coexisting disease such as chronic obstructive
pulmonary disease (COPD). In patients with COPD, the morbidity and mortality caused by an influenza
virus infection are considerably greater.
In a COPD/emphysema mouse model, influenza A virus (IAV) infection reworked lung clock gene
expression and decreased the amplitude in the rhythms of locomotor activity. This effect was more
prominent in C57BL/6J mice that were chronically exposed to cigarette smoke and was accompanied
by decreased body weight and augmented mortality; likewise, Bmal1 knockout mice infected with IAV
showed amplified lung inflammatory and pro-fibrotic responses.
Furthermore, the time of day of virus infection crucially impacts the outcome of IAV and this
effect is observed under different types of light–dark cycles (12-h light/12-h darkness versus constant
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darkness), as well as in genetic circadian disruption models. The time of infection impacted late-viral
clearance and IAV survival in Bmal1fl/fl Ercre+ mice, and this time-of-day observed variation was abolished
in Bmal1−/− mice. The rhythmic fluctuation of IAV-dependent effects was driven by inflammatory
changes in the lung favouring better survival and related to a time point with high proportion of natural
killer cells and of natural killer T lymphocytes and small percentages of inflammatory monocytes [70].
Accordingly, experiments performed in mice with targeted Bmal1 deletion in pulmonary airway
epithelial cells (AECs), cellular elements that vitally shape the host/environment boundary, induced
alterations in neutrophil infiltration, biomechanical function, and responses to influenza infection in
the lungs. Analysis of the 24-h time-resolved RNA sequencing performed on laser-captured AECs
indicates that extensive transcriptomic changes in circadian enriched pathways are linked to lipid
metabolism, xenobiotic detoxification, extracellular matrix, and chemokine signalling [71].
The Bmal1 knockout findings suggest that proper functioning of the molecular clockwork is
necessary for the immune response towards viral infections and the subsequent disease [72].
1.8. Epigenetic Mechanisms Underlying the Interaction Between Viral Infection and the Circadian
Clock Machinery
Epigenetic regulatory mechanism, which includes DNA methylation and histone posttranslational
modifications (PTM), leads to chromatin remodelling and regulated gene expression. Chromatin
remodelling represents a critical process through which inputs, such as light or food, are transduced
by the cell to generate permissive and silencing histone modifications to influence gene transcription
and ultimately signalling pathway activity. CLOCK-BMAL1-dependent activation of clock-controlled
genes is connected to circadian changes in histone PTM at their own promoters. Numerous chromatin
remodelers, such as the deacetylases Sirtuin 1 (SIRT1, a NAD+-dependent histone deacetylase) and
histone deacetylase 3 (HDAC3), are recruited to the promoter region of the clock-controlled genes in a
circadian manner [34,73]. Importantly, the core element of the clockwork machinery, the transcription
factor CLOCK, displays histone acetyltransferase activity as well. In the absence of these chromatin
modifiers, the rhythmic expression of the clock-controlled genes is abrogated [73]. One of the most
common epigenetic modifications is the methylation of DNA (addition of a methyl group to the cytosine
residue in CpG dinucleotides mediated by the family of DNA methyltransferase enzymes DNMT1,
DNMT3a, and DNMT3b). Overall DNA methylation with focal hypermethylation on the promoter of
tumour suppressor genes, causing transcriptional silencing, is a mechanism of carcinogenesis [74–76].
These epigenetic mechanisms are critical for the functioning of the biological clock [73] and are
disrupted by viral infection [74–76].
Previous studies report the existence of an interplay between the molecular clockwork, epigenetic
modifications, and hepatitis C virus (HCV) in the liver, which affects ~3% of the population worldwide.
Infection with HCV is considered one of the main risk factors for hepatocellular carcinoma (HCC) [77].
HCV is clustered into six main genotypes (in turn divided into various subtypes) [78]. Abundant
evidence has demonstrated that HCV-related pathogenesis and its impact on liver disease is dependent
on the genotype and that genetic and epigenetic mechanisms underlay viral interaction with cell
processes and the molecular clockwork [79].
In the in vitro model of Huh-7 cells transfected with HCV core protein of different genotypes
(1b, 2a, 3a, 4h, and 5a) [80], cellular DNMT1 and DNMT3b protein levels were increased in genotype
1b or 3a HCV core-expressing cells as compared to control cells [75]. Changes in the balance of
DNA methylation mediated by DNMTs has been directly linked to HCV-dependent increase in
hepatocarcinogenesis and in particular in the onset of hepatocellular carcinoma (HCC), hallmarked
by global DNA hypomethylation and local hypermethylation on the promoter of tumour suppressor
genes [74]. A recent meta-analysis showed that reduced E-cadherin (CDH1) expression is a predictor
of poor prognosis in HCC patients [81]. CDH1 promoter is massively hypermethylated in genotype
1b HCV core protein-positive Huh-7 cells, in turn leading to reduced levels of CDH1 protein and
increased levels of SIRT1 [76]. HCV-dependent alterations in SIRT1 function/activity have been shown
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by several studies performed in different cellular models [82–86]. In turn, SIRT1 is a well-established
regulator of the circadian oscillation of clock-controlled genes in the liver, controlling fat metabolism,
cell proliferation, and regeneration [87,88]. HCV has been shown to affect directly the circadian
clock machinery. In Huh-7 cells expressing the HCV core protein genotype 1b, but not 3a, protein
levels of PER2 and CRY2 were found decreased [79]. Reciprocally, overexpression of PER2 led to
a consistent decrease in the levels of HCV RNA undergoing replication [79]. Furthermore, in liver
biopsies from HCV genotype 1b-infected patients, PER2 was almost exclusively localized to the nucleus,
which is suggestive of an auto-inhibitory transcriptional feedback loop [79]. More recently, it was
shown that the core-clock components BMAL1 and REV-ERBα act upon more steps in the HCV life
cycle, including the entry of viral particles into hepatocytes and the replication of the viral RNA [89].
In fact, pharmacological activation of REV-ERB inhibited HCV entry, and genetic knockout of Bmal1
or overexpression/pharmacological activation of REV-ERB was able to counteract HCV replication
by modulating the circadian expression of the liver-specific microRNA miR-122 with consequent
derangements of signalling pathways involved in lipid metabolism [89]. A better understanding of
circadian modulation of HCV life cycle and dynamic/rhythmic patterns of host–hosted interplay might
lead to increased efficacy of therapies for HCV infection-related diseases.
2. Conclusions
Infectious agents exploit infected organisms in order to survive, multiply, settle, and eventually
spoil. While some infections may remain asymptomatic or scarcely manifest, others are treatment
resistant and have a grim prognosis. The immune system efficiently shields the body against
infectious agents but eventually may fail, with harsh outcomes for the infected organism. Viruses are
intracellular parasites hinging on the host cellular structures and cellular processes to replicate, survive,
and disseminate. The biological clock drives circadian rhythmicity of cellular processes and immune
functions, thus shaping the host response to viral infections and affecting the patterns of host–pathogen
interaction [90]. Similarly to other infectious diseases, viral infections impact the circadian clock
circuitry of the infected organism that, in turn, interacts with the molecular components of the
infecting pathogens, pointing to a role of timing in this complex interplay and to a possible advantage
of applying chrono-modulated antiviral therapeutic strategies. The contemporary chronotherapy
employed or proposed in metabolic, immune, and neoplastic diseases could better address the outline
of host–pathogen interaction, advancing the efficacy of antiviral therapy and improving the outcome
of treatment of viral infections.
Even though much has been investigated in the circadian clock/immune system field in recent years,
several open and outstanding questions remain to be addressed. Are different branches of the immune
system differentially regulated by circadian rhythms? If autonomous ticking is dampened in peripheral
tissues, do peripheral immune cells alter their rhythms/responses relative to immune cells in the
thymus and lymph nodes? Do responses to vaccines that need boosters show different time-dependent
patterns? Would different adjuvants boost vaccine responses in a time-of-day-dependent manner? Does
deregulation of circadian rhythms correlate with reactivation of viruses known to cause latent infections
(herpes simplex virus, varicella zoster virus, Epstein–Barr virus, human cytomegalovirus, human
herpesvirus 6, human herpesvirus 7, Kaposi’s sarcoma-associated herpesvirus, JC virus, BK virus,
parvovirus, and adenovirus)? Do hibernating animal species mount different antiviral responses
during hibernation? These are extremely interesting topics for future research, and the answers to the
questions above will help pave new directions in the study of circadian–immune network interactions
in the context of viral infections.
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